Cover Page - USD ($) $ in Millions |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Jan. 31, 2023 |
Jun. 30, 2022 |
|
| Document Information [Line Items] | |||
| Document Type | 10-K/A | ||
| Document Annual Report | true | ||
| Document Period End Date | Dec. 31, 2022 | ||
| Document Transition Report | false | ||
| Entity File Number | 001-40154 | ||
| Entity Registrant Name | Oscar Health, Inc. | ||
| Entity Incorporation, State or Country Code | DE | ||
| Entity Tax Identification Number | 46-1315570 | ||
| Document Fiscal Year Focus | 2022 | ||
| Document Fiscal Period Focus | FY | ||
| Amendment Flag | true | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity Central Index Key | 0001568651 | ||
| Entity Address, Address Line One | 75 Varick Street, 5th Floor | ||
| Entity Address, City or Town | New York | ||
| Entity Address, State or Province | NY | ||
| Entity Address, Postal Zip Code | 10013 | ||
| City Area Code | 646 | ||
| Local Phone Number | 403-3677 | ||
| Title of 12(b) Security | Class A Common Stock, $0.00001 par value per share | ||
| Trading Symbol | OSCR | ||
| Security Exchange Name | NYSE | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Large Accelerated Filer | ||
| Entity Small Business | false | ||
| Entity Emerging Growth Company | false | ||
| ICFR Auditor Attestation Flag | true | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 727.7 | ||
| Documents Incorporated by Reference | Portions of the registrant’s definitive Proxy Statement relating to its 2023 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of the fiscal year ended December 31, 2022 are incorporated herein by reference in Part III. | ||
| Amendment Description | Oscar Health, Inc. (the “Company”) is filing this Amendment No. 1 (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was originally filed with the Securities and Exchange Commission on February 24, 2023 (the “Form 10-K”), to correct inadvertent omissions pertaining to certain references to internal control over financial reporting that were required to be provided in the Section 302 Certifications of our principal executive officer and principal financial officer (the “Section 302 Certifications”) as filed with the Form 10-K. The Exhibits 31.1 and 31.2 filed with the Form 10-K omitted from the Section 302 Certifications: (i) the introductory language in paragraph 4 that refers to the certifying officer’s responsibility for establishing and maintaining internal control over financial reporting for the Company; and (ii) paragraph 4(b) regarding the design of internal control over financial reporting. The Company hereby amends the Form 10-K by resubmitting corrected versions of Exhibits 31.1 and 31.2 with this Amendment. This Amendment does not reflect events occurring after the filing of the Form 10-K or modify or update those disclosures affected by subsequent events. Except for the items described above or contained in this Amendment, this Amendment continues to speak as of the date of the Form 10-K, and does not modify, amend or update any other item or disclosures in the Form 10-K. | ||
| Auditor Name | PricewaterhouseCoopers LLP | ||
| Auditor Firm ID | 238 | ||
| Auditor Location | Philadelphia, Pennsylvania | ||
| Class A | |||
| Document Information [Line Items] | |||
| Entity Common Stock, Shares Outstanding | 181,187,578 | ||
| Class B | |||
| Document Information [Line Items] | |||
| Entity Common Stock, Shares Outstanding | 35,115,807 |